Pulmonary delivery of EGFR (Epidermal Growth Factor Receptor)-targeted SPIO (Superparamagnetic Iron Oxide) nanoparticles improved tumor retention and significantly inhibited lung tumor growth through hyperthermic destruction of NSCLC [155] (Table 2). This evidence concerns the gene EGFR and non-small cell lung carcinoma.